Skip to content
LAWYER PROFILE

Covington & Burling LLP

Krista Hessler Carver

Washington, DC, USA Global Guide 2021 Ranked in 1 departments
Ranked in : Life Sciences: Regulatory/Compliance
chambers review
Lawyer Information
chambers review
Lawyer Information

Lawyer profile for Global 2021

Profile view:
Global 2021
Global

This individual is also ranked in:

USA 2021

Chambers Review

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

Global
Life Sciences: Regulatory/Compliance - USA

Up and Coming

Krista Carver counsels pharmaceutical and biotechnology businesses on legislative and regulatory developments and procedure, including Hatch-Waxman compliance, life-cycle management, digital health and orphan drugs. She frequently represents clients before the FDA.
View ranking table

Lawyer information

This content is provided by Krista Hessler Carver

Practice Areas

Krista Carver is a co-chair of Covington’s Life Sciences – Pharmaceutical and Biotechnology Industry Group. Drawing on her nearly 15 years of experience, she provides strategic and practical advice to clients on an array of FDA regulatory issues. Her areas of focus include biosimilars, orphan drug, and Hatch-Waxman regulatory issues; digital health; gene therapies; pediatric testing; regulatory exclusivities and life cycle management strategies; risk evaluation and mitigation strategies (REMS); pharmacovigilance; and issues regarding medical products for COVID-19, including emergency use authorizations. Ms. Carver also assists clients with advocacy before FDA, including formal dispute resolution requests and citizen petitions. She also maintains an active policy practice, addressing legislative issues surrounding amendments to the Federal Food, Drug, and Cosmetic Act and related laws.

Publications

Ms. Carver writes and speaks regularly on subjects such as biosimilars and life sciences legislation. She co-authored a comprehensive article on the BPCIA, “An Unofficial Legislative History of the Biologics Price Competition and Innovation Act of 2009” (Food and Drug Law Journal, 2010) and the United States Chapter in the Life Sciences Law Review.

Personal

Harvard Law School, J.D., 2006; B.S., Chemistry, William & Mary, 2003.

Global

This individual is also ranked in:

USA 2021
Krista Hessler Carver

Covington & Burling LLP

phone
Phone number
firm
Office

One CityCenter, 850 Tenth Street

NW

Washington, DC

District of Columbia

USA

20001-4956

guide
Ranked In

Global 2021

View Firm Profile
Share profile:

Discover other lawyers at Covington & Burling LLP

View firm profile
Richard F Kingham
Senior Statespeople
Richard F KinghamCovington & Burling LLPLife Sciences: Regulatory/Compliance Washington, DC, USA
Richard F Kingham
Senior Statespeople
Richard F KinghamCovington & Burling LLPLife Sciences: Regulatory/Compliance Washington, DC, USA
Michael S Labson
Band 1
Michael S LabsonCovington & Burling LLPLife Sciences: Regulatory/Compliance Washington, DC, USA
Michael S Labson
Band 1
Michael S LabsonCovington & Burling LLPLife Sciences: Regulatory/Compliance Washington, DC, USA
Denise Esposito
Band 2
Denise EspositoCovington & Burling LLPLife Sciences: Regulatory/Compliance Washington, DC, USA
Denise Esposito
Band 2
Denise EspositoCovington & Burling LLPLife Sciences: Regulatory/Compliance Washington, DC, USA
Peter O Safir
Senior Statespeople
Peter O SafirCovington & Burling LLPLife Sciences: Regulatory/Compliance Washington, DC, USA
Peter O Safir
Senior Statespeople
Peter O SafirCovington & Burling LLPLife Sciences: Regulatory/Compliance Washington, DC, USA